does tirzepatide cause blindness Ozempic and vision loss: GLP-1 drugs may double risk of eye disease Scientists Explain 'Ozempic Blindness,' Link

It is a metabolic optimizer, not a transformation drug

Rossiello MR, Rotunno C, Coluccia A et al (2008) Ochratoxin A inhibits the production of tissue factor and plasminogen activator inhibitor-2 by human blood mononuclear cells: another potential mechanism of immune-suppression

Des Jardins says that Datassentials research suggests that restaurant operators, for example, are currently split on how to approach this market: 42% are considering adding GLP-1 friendly items, but 43% report they arent yet interested

Alarmingly, of all approved prescriptions for diabetes GLP-1s, 15% are never filled , meaning patients walk away before even starting therapy, despite having an approved script